Potassium 2-(1-hydroxypentyl)-benzoate improves learning and memory deficits in chronic cerebral hypoperfused rats

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 155-160

  Zhao, Wanhong ^a,b   Xu, Shaofeng ^a   Peng, Ying ^a   Ji, Xincai ^a   Cao, Dongxu ^a   Li, Jiang ^a   Liu, Bin ^a   Shi, Qiaoqiao ^a   Wang, Ling ^a   Wang, Xiaoliang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Astrocyte activation; Chronic cerebral hypoperfusion; Oxidative damage; Potassium 2 (1 hydroxypentyl) benzoate; White matter impairment

Indexed keywords

3 BUTYLPHTHALIDE; LIPID PEROXIDE; NOOTROPIC AGENT; PIRACETAM; POTASSIUM 2 (1 HYDROXYPENTYL) BENZOATE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CELL ACTIVATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; LEARNING DISORDER; LONG TERM CARE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPATIAL LEARNING; THERAPY EFFECT; TREATMENT DURATION; WHITE MATTER LESION;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ASTROCYTES; BENZOATES; BRAIN; CAROTID ARTERY DISEASES; CHRONIC DISEASE; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; OXIDATIVE STRESS; PENTANES; RATS; RATS, WISTAR;

EID: 84876412588     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.01.053     Document Type: Article

References (23)

1. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cerebr. Blood F. Met. 2001, 21:2-14.
2. Desmond D.W. Vascular dementia. Clin. Neurosci. Res. 2004, 3:437-448.
3. Dong G.X., Feng Y.P. Effects of NBP on ATPase and anti-oxidant enzymes activities and lipid peroxidation in transient focal cerebral ischemic rats. Acta Academiae Med. Sinicae 2002, 24:93-97.
4. Gunstad J., Brickman A.M., Paul R.H., Browndyke J., Moser D.J., Ott B.R., Gordon N., Haque O., Cohen R.A. Progressive morphometrie and cognitive changes in vascular dementia. Arch. Clin. Neuropsych. 2005, 20:229-241.
5. Kalaria R.N., Kenny R.A., Ballard C.G., Perry R., Ince P., Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J. Neurol. Sci. 2004, 226:75-80.
6. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Bio. Med. 1997, 23:134-147.
7. Morris R.G. Developments of water-maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 1984, 11:47-60.
8. Nanri M., Watanabe H. Availability of 2VO rats as a model for chronic cerebrovascular disease. Nippon Yakurigaku Zasshi 1999, 113:85-95.
9. Ni J.W., Matsumoto K., Li H.B., Murakami Y., Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion bilateral common carotid arteries in rats. Brain Res. 1995, 673:290-296.
10. Ohta H., Nishikawa H., Kimura H., Anayama H., Miyamoto M. Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats. Neuroscience 1997, 79:1039-1050.
11. Olsson Y., Brun A., Englund E. Fundamental pathological lesions in vascular dementia. Acta Neurol. Scand. Supplementum 1996, 168:31-38.
12. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659.
13. Peng Y., Xu S.F., Chen G.Q., Wang L., Feng Y.P., Wang X.L. l-3-n-butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J. Pharmacol. Exp. Ther. 2007, 321:902-910.
14. Peng Y., Xu S.F., Wang L., Feng Y.P., Wang X.L. Effect of L-3-n-butylphthalide on cerebral infarct volume in the transient cerebral ischemia rats. Chinese J. New Drug 2005, 14:420-423.
15. Sakakibara Y., Mitha A.P., Ogilvy C.S., Maynard K.I. Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats. Neurosci. Lett. 2000, 281:111-114.
16. Tiurenkov I.N., Bagmetov M.N., Epishina V.V. Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia. Eksp. Klin. Farmakol. 2007, 70:24-29.
17. Tsuchiya M., Sako K., Yura S., Yonemasu Y. Local cerebral glucose utilization following acute and chronic bilateral carotid artery ligation in Waster rats: relation to changes in local cerebral blood flow. Exp. Brain Res. 1993, 95:1-7.
18. Wakita H., Tomimoto H., Akiguchi I., Matsuo A., Lin J.X., Ihara M., McGeer P.L. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res. 2002, 924:63-70.
19. Watanabe T., Zhang N., Liu M., Tanaka R., Mizuno Y., Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006, 37:1539-1545.
20. Xu H.L., Feng Y.P. Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol. Sin. 2000, 21:433-438.
21. Yin L., Ohtaki H., Nakamachi T., Kudo Y., Makino R., Shioda S. Delayed expressed TNFR1 co-localize with ICAM-1 in astrocyte in mice brain after transient focal ischemia. Neurosci. Lett. 2004, 370:30-35.
22. Zhang Y., Wang L., Li J., L X. Wang, 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia. J. Pharmacol. Exp. Ther. 2006, 317:973-979.
23. Zhang Y., Wang L., Zhang L., Wang X. Effects of 2-(1-hydroxypentyl)-benzoate on Platelet Aggregation and Thrombus formation in rats. Drug Dev. Res. 2004, 63:174-180.